Skip to main content
logo
Petros Pharmaceuticals, Inc. (PTPI)
OTCMKTS · Delayed Price · Currency is USD
0.0040
-0.00208 (-34.21%)
At close: Sep 18, 2026

Petros Pharmaceuticals Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
---5.825.997.81
Revenue Growth
----2.83%-23.29%-18.29%
Gross Profit
---4.193.76.21
Operating Income
-3.4-4.64-4.63-10.76-15.85-18.05
Net Income
-17.36-43.69-26.8-13.81-20.04-8.99
Earnings Per Share
-0.39-1.56-83.47-158.71-241.98-206.31
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
3.495.141.7213.349.4323.85
Total Debt
---8.289.880.53
Net Cash (Debt)
3.495.141.725.06-0.4623.32
Net Cash Growth
-52.35%198.88%-66.04%--150.05%
Net Cash Per Share
0.080.185.3558.14-5.51535.30

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-3.72-6.73-2.6-7.63-12.8-11.86
Capital Expenditures
------
Free Cash Flow
-3.72-6.73-2.6-7.63-12.8-11.86
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
---71.98%61.79%79.52%
Operating Margin
----184.84%-264.44%-231.05%
Pretax Margin
----140.20%-334.40%-115.05%
Profit Margin
----237.26%-334.40%-115.05%
FCF Margin
----130.99%-213.57%-151.86%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
---0.530.818.80